Trial intelligence / Profile preview

Tacalcitol 20 mcg/g vs 2 mcg/g ointment in psoriasis vulgaris

jRCT2080220840Phase 3

Sponsor
Teijin Pharma
Start
Sep 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of tacalcitol in plaque psoriasis (2 arms), sponsored by Teijin Pharma.

02

Drugs

tacalcitol
03

Conditions

plaque psoriasis

Beyond the preview

Go deeper on jRCT2080220840.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080220840.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call